Status:
NOT_YET_RECRUITING
Added Value of PET/CT in Lung Cancer
Lead Sponsor:
Sohag University
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Assess the value of PET/CT in the diagnosis, staging, response evaluation, and relapse monitoring of lung cancer.
Detailed Description
Lung cancer is a leading cause of cancer-related mortality worldwide, accounted for 1.80 million deaths in 2020.(1)Egyptian statistics showed that lung cancer in men represents 8.2% of among all cance...
Eligibility Criteria
Inclusion
- Pathologically proven lung cancer patients.
Exclusion
- Patients with second malignancy.
- Severely ill patient (patient with disturbed consciousness level, or couldn't lie during the imaging).
- Uncontrolled diabetic patient with blood glucose level more than 200mg\\dl.
- Pregnant women.
- Patient age \<18 years.
Key Trial Info
Start Date :
July 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06494800
Start Date
July 15 2024
End Date
December 1 2025
Last Update
July 10 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.